Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
In recent investment activity, Julie Johnson, the congressional representative for Texas's 32nd district, has made several stock transactions in her Merrill Lynch Tax Efficient Core, Merrill Lynch ...
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
The Pantera icon loved digging into his Riffer Madness “Feedback Sack” and answering readers’ questions. Here he offers gear ...
Data center developer ImpactData has partnered with Raeden for its debut data center in North Carolina. Raeden signed a joint ...
The data cutoff date for the current analysis of the study was August 8, 2024. With 29.1 months of median follow-up, 12% of ...
The Milwaukee Bucks (26-19) and San Antonio Spurs (20-24) meet Friday. Tip-off from Frost Bank Center is scheduled for 8 p.m. ET. Let's analyze BetMGM Sportsbook's NBA odds around the ...
Campbell Hall makes a third-quarter comeback and will next play Crespi on Friday; plus other scores from Wednesday’s first ...
Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that it costs $100 to $300 million to develop a biosimilar and that it takes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback